Is it Still Worthy to Keep Your Zimmer Biomet (ZBH) Stake?
Ariel Investments, an investment management firm, published its “Ariel Focus Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Zimmer Biomet Holdings Inc. (ZBH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Camber Capital Management Stephen Dubois | 1,350,000 | $172,665 | +35% | 6.24% |
| 2. | Ariel Investments John W. Rogers | 417,700 | $53,424 | +7% | 0.47% |
| 3. | D E Shaw D. E. Shaw | 414,247 | $52,982 | -60% | 0.04% |
| 4. | Bridgewater Associates Ray Dalio | 413,910 | $52,939 | +58% | 0.21% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 411,164 | $52,588 | +364% | 0.16% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $171.58 | 1,000 | Director | 3,400 | 2021-05-06 | Filing | |
| $113.00 | 1,000 | Officer, Director | 54,568 | 2020-05-13 | Filing | |
| $125.52 | 1,925 | Director | 1,925 | 2019-03-01 | Filing | |
| $123.28 | 500 | Director | 2,400 | 2019-02-15 | Filing | |
| $123.62 | 2,000 | Director | 2,000 | 2019-02-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $122.46 | 5,331 | Officer | 41,539 | 2022-03-17 | Filing | |
| $121.90 | 29,518 | Officer | 46,870 | 2022-03-17 | Filing | |
| $120.69 | 300 | Officer | 76,388 | 2022-03-17 | Filing | |
| $124.18 | 200 | Officer | 5,837 | 2021-12-14 | Filing | |
| $124.14 | 2,600 | Officer | 6,037 | 2021-12-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 780,402 | $99,813,417 | 0.04% | |
| 2. | 107,154 | $13,704,997 | 0.01% | |
| 3. | 111,186 | $10,800,659 | 0.15% | |
| 4. | 63,890 | $8,171,531 | 0.04% | |
| 5. | 455 | $5,819,450 | 0% |
News See All
5 Best Healthcare Stocks To Buy In 2022
On February 7, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported earnings for the fourth quarter, posting an EPS of $1.95, missing estimates by $0.03. Zimmer Biomet Holdings, Inc.
Did The Smart Money Get Zimmer Biomet Holdings Inc (ZBH) Right?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Biotech Stocks in Billionaire Ray Dalio’s Portfolio
In this piece, we will take a look at the 10 biotech stocks in billionaire Ray Dalio's portfolio. If you want to jump ahead to the top five stocks in the list and skip the details about Mr.
10 Healthcare Stocks to Buy Now According to Billionaire Louis Bacon
In this article, we discuss the 10 healthcare stocks to buy now according to billionaire Louis Bacon.
Is Zimmer Biomet Holdings Inc (ZBH) Going to Burn These Hedge Funds?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Billionaire David Harding is Buying These 5 Stocks
In this article, we will be looking at the 5 stocks billionaire David Harding is currently buying.
10 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments
In this article, we will take a look at the 10 healthcare stocks to buy according to John Rogers’ Ariel Investments.
Were Hedge Funds Right About Zimmer Biomet Holdings Inc (ZBH)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
10 Pharmaceutical Stocks to Buy According to Lawrence Hawkins’ Prosight Capital
In this article, we discuss 10 pharmaceutical stocks to buy according to Lawrence Hawkins' Prosight Capital.
Billionaire Hedge Funds
